Connection

Richard Drake to Antineoplastic Agents

This is a "connection" page, showing publications Richard Drake has written about Antineoplastic Agents.
Connection Strength

0.509
  1. Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells. Oncol Rep. 2005 Nov; 14(5):1323-30.
    View in: PubMed
    Score: 0.147
  2. Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA. Clin Cancer Res. 2021 01 01; 27(1):226-236.
    View in: PubMed
    Score: 0.104
  3. Two-drug combinations that increase apoptosis and modulate bak and bcl-X(L) expression in human colon tumor cell lines transduced with herpes simplex virus thymidine kinase. Cancer Gene Ther. 2000 Apr; 7(4):563-73.
    View in: PubMed
    Score: 0.100
  4. Differential ganciclovir-mediated cell killing by glutamine 125 mutants of herpes simplex virus type 1 thymidine kinase. J Biol Chem. 1999 Dec 24; 274(52):37186-92.
    View in: PubMed
    Score: 0.098
  5. LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria. J Pharmacol Exp Ther. 2013 Jan; 344(1):167-78.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.